Cantor Fitzgerald Europe lowers stake in SymBio Pharmaceuticals to 7.44%
Stake history
Summary
Cantor Fitzgerald Europe filed a Change in 5%+ stake (change report) via EDINET on 2025-03-25 10:05 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 7.44%, previous report: 9.11%.